Antidepressant discontinuation led to adverse symptoms one‐third of the time.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Source:
    Brown University Psychopharmacology Update. Oct2024, Vol. 35 Issue 10, p1-6. 6p.
  • Additional Information
    • Subject Terms:
      NAUSEA -- Risk factors; PATIENT compliance; RISK assessment; DIZZINESS; HEADACHE; INSOMNIA; DRUG therapy; AFFECTIVE disorders; ANTIDEPRESSANTS; DRUGS; DISEASE relapse; MENTAL depression; DISEASE risk factors
    • Abstract:
      A systematic review and meta‐analysis encompassing 79 studies has found that around one‐third of patients who discontinue antidepressant medication will experience adverse symptoms, but only around 1 in 30 will experience severe discontinuation symptoms. An analysis of individual antidepressants found that imipramine, desvenlafaxine, and venlafaxine were associated with the highest incidence of discontinuation symptoms. Results were published online June 5, 2024, in Lancet Psychiatry. [ABSTRACT FROM AUTHOR]
    • Abstract:
      Copyright of Brown University Psychopharmacology Update is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)